Grace Therapeutics (GRCE) Goodwill (2022 - 2026)

Grace Therapeutics has disclosed Goodwill across 5 years of filings, most recently posting $8.1 million for Q2 2026.

• In Q2 2026, Goodwill changed 0.0% year-over-year to $8.1 million; the TTM figure through Jun 2026 stood at $8.1 million (changed 0.0% YoY), while the FY2026 annual figure was $8.1 million, changed 0.0% from the prior year.
• Goodwill came in at $8.1 million for Q2 2026 at Grace Therapeutics, roughly flat from $8.1 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $13.0 million in Q1 2022 to a low of $8.1 million in Q1 2023.
• Average Goodwill over 5 years is $9.2 million, with a median of $8.1 million recorded in 2023.
• Year-over-year, Goodwill tumbled 37.23% in 2023 and changed 0.0% in 2024.
• Over 5 years, Goodwill stood at $13.0 million in 2022, then tumbled by 37.23% to $8.1 million in 2023, then changed by 0.0% to $8.1 million in 2024, then changed by 0.0% to $8.1 million in 2025, then changed by 0.0% to $8.1 million in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $8.1 million in Q2 2026, $8.1 million in Q1 2026, and $8.1 million in Q4 2025.